DOCICAR: Cardiac Dysfunction in Cirrhosis

Hvidovre University Hospital

Status: Completed

Conditions: Cirrhosis; Cirrhotic Cardiomyopathy

Treatments: Drug: Dobutamine

Study type: Observational

Funder types: Other

Identifiers

NCT00250315

(KF) 01 270675

Details and patient eligibility

About

Patients with cirrhosis have a altered cardiac response to stress. This study evaluate the cardiac response by MRI during dobutamine stress. Hypothesis: impared increase in cardiac output, cardiac index, ejection fraction.

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Non alkoholic cirrhosis

Exclusion criteria

• Coma hepaticum
• Primary cardiac diseases